Late last week, President Trump announced two new rules that he said would save Medicare enrollees billions of dollars in drug costs. They are unlikely to save a nickel. While there is a lot less to these new rules than President Trump claims, the real question is what steps President-elect Joe Biden and a divided Congress will take to lower [...]
The Trump Administration has proposed a major change in the way drugs are priced for Medicare beneficiaries. The new rules would upend the current complex and opaque pricing system for pharmaceuticals, lower prices for users of some costly drugs (though not others), and raise Medicare Part D premiums for everyone. Whether you win or lose under the new system would [...]
The Trump Administration is heavily promoting what it calls its “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” But will the plan reduce out-of-pocket costs for Medicare beneficiaries? The answer is: Not by much, at least not very soon. And, in some cases, it could even make drugs more costly. The first problem is that the paper really isn’t [...]
While most proposals in President Trump’s newly released 2019 budget are unlikely to become law, the fiscal framework does show the White House’s priorities for government over the coming year. And those apparently don’t include support for older adults, younger people with disabilities, or their families. For example, the budget would: Restructure the Medicare drug benefit to reduce costs for [...]
After spending 19 months trying to figure out how to make the Community Living Assistance Services and Supports (CLASS) Act work, the Obama Administration has abandoned the landmark national long-term care insurance program that was included in the 2010 health reform law. But it was easier for the Administration and vocal GOP critics of the program to kill CLASS than [...]